From: Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial
Restricted group (n = 30) | Standard group (n = 32) | p-value* | |
---|---|---|---|
Characteristics | |||
Age (yrs) | 55.5 (15.4) | 53.6 (15.0) | 0.623 |
Sex (Male/Female) | 19/11 | 21/11 | 0.853 |
Height (m) | 1.73 (0.08) | 1.76 (0.08) | 0.810 |
Weight (kg) | 69.9 (12.5) | 76.5 (17.1) | 0.908 |
BMI | 23.2 (4.2) | 24.5 (4.7) | 0.408 |
ASA | 0.908 | ||
1 | 4 (13%) | 5 (16%) | |
2 | 21 (70%) | 24 (75%) | |
3 | 5 (17%) | 3 (9%) | |
Type of surgery | 0.522 | ||
-Gastric | 0 (0%) | 1 (3%) | |
-Pancreas | 14 (47%) | 11 (34%) | |
-Bile duct | 7 (23%) | 9 (28%) | |
-Gall bladder | 0 (0%) | 1 (3%) | |
-Small bowel | 2 (7%) | 3 (9%) | |
-Colon | 3 (10%) | 4 (13%) | |
-Rectum | 3 (10%) | 1 (3%) | |
-Adrenal gland | 0 (0%) | 1 (3%) | |
-Retroperitoneal tumor | 0 (0%) | 1 (3%) | |
-Explorative laparotomy | 1 (3%) | 0 (0%) |